What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.91%Above 5Y avg (0.41%)
Annual Rate
CNY 0.18Paid annual
Payout Ratio
47.0%Sustainable
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.44BCNY
1.26B · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
50.24x
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
2.40BCNY
359.43M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
6.84%
vs Medical Devices peers
Updated Oct 21, 2026
Beta
-0.3960x
vs all stocks
Updated Oct 21, 2026
52-Week Change
-40.05%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
8.44BCNY
1.26B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
7.12BCNY
1.07B · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
50.24x
vs Medical Devices peers
Updated Oct 21, 2026
Forward P/E
19.48x
vs Medical Devices peers
Updated Oct 21, 2026
Price to Sales (TTM)
3.38x
vs Medical Devices peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.52×.Updated Oct 21, 2026
Price to Book (MRQ)
2.67x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to Revenue
2.97x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to EBITDA
32.10x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 21.89×.Updated Oct 21, 2026
Gross Margin
60.40%
vs Medical Devices peers
Updated Oct 21, 2026
Profit Margin
6.84%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Margin
2.85%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Assets (TTM)
2.07%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Equity (TTM)
5.35%
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
2.40BCNY
359.43M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
5.60CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
7.20%
vs Medical Devices peers
Updated Oct 21, 2026
Gross Profit (TTM)
1.43BCNY
214.91M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
325.37MCNY
48.77M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
164.03MCNY
24.59M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-34.80%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
95.55MCNY
14.32M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-49.41MCNY
-7.41M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.1800CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.91%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.41%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
46.97%
vs Medical Devices peers
Updated Oct 21, 2026
Revenue
2.31BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
877.69MCNYFY2025 · Dec 31, 2025
Gross Profit
1.43BCNYFY2025 · Dec 31, 2025
Operating Income
184.45MCNY
27.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
164.19MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-33.09MCNYFY2025 · Dec 31, 2025
Net Income
197.28MCNYFY2025 · Dec 31, 2025
EBIT
168.35MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
325.37MCNYFY2025 · Dec 31, 2025
Research & Development
495.78MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
283.97MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
21.27MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
35.63MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.16MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4600CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4600CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
428.87MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
428.87MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
197.28MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-193.94MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-336.05MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
197.28MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
8.19MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-72.76MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-326.65MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-142.11MCNYFY2025 · Dec 31, 2025
Sale of Investments
5.75MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-72.10MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-208.46MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
230.68MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-262.09MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-47.23MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-11.77MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-90.41MCNYFY2025 · Dec 31, 2025
Shares Outstanding
424.84MSharesUpdated Oct 21, 2026
Float Shares
182.57MSharesUpdated Oct 21, 2026
% Held by Insiders
56.35%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
8.59%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
1.09BCNY
162.88M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
2.57CNYUpdated Oct 21, 2026
Total Debt (MRQ)
300.95MCNY
45.11M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.0998x
vs Medical Devices peers
Updated Oct 21, 2026
Current Ratio (MRQ)
2.98x
vs Medical Devices peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
7.14CNYUpdated Oct 21, 2026
Total Assets
4.41BCNY
660.46M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.82BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.14BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.59BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
123.65MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.02BCNYFY2025 · Dec 31, 2025
Cash
1.43BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.43BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
237.16MCNYFY2025 · Dec 31, 2025
Accounts Receivable
300.53MCNYFY2025 · Dec 31, 2025
Inventory
763.60MCNYFY2025 · Dec 31, 2025
Accounts Payable
367.11MCNYFY2025 · Dec 31, 2025
Short-term Debt
245.01MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.13MCNYFY2025 · Dec 31, 2025
Long-term Debt
65.13MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
432.71MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.57BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.26BCNY
489.01M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
120.03MCNYFY2025 · Dec 31, 2025
52-Week Low
17.20CNYUpdated Oct 21, 2026
52-Week High
34.45CNYUpdated Oct 21, 2026
52-Week Change
-40.05%
vs all stocks
Updated Oct 21, 2026
Beta
-0.3960x
vs all stocks
Updated Oct 21, 2026
50-Day MA
19.65CNYUpdated Oct 21, 2026
200-Day MA
22.74CNYUpdated Oct 21, 2026
Avg 10-Day Volume
4.69MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
4.26MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.3800CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable